Novo Nordisk AS (LTS:0QIU)
kr 321 +2.3 (+0.72%) Market Cap: 1.42 Tn Enterprise Value: 1.54 Tn PE Ratio: 11.70 PB Ratio: 7.01 GF Score: 79/100

Q1 2020 Novo Nordisk A/S Earnings Presentation Transcript

May 07, 2020 / 12:15PM GMT
Release Date Price: kr215.58 (-0.01%)

May 07, 2020 / 12:15PM GMT
Presentation
May 07, 2020 / 12:15PM GMT

=====================
Corporate Participants
=====================
* Camilla Sylvest
Novo Nordisk A/S - Executive VP, Head of Commercial Strategy & Corporate Affairs and Member of the Management Board
* Karsten Munk Knudsen
Novo Nordisk A/S - Executive VP, CFO & Member of the Management Board
* Mads Krogsgaard Thomsen
Novo Nordisk A/S - Executive VP, Chief Science Officer & Member of the Management Board

=====================
Conference Call Participants
=====================
* Jiaxi Liu
* Keyur Parekh
Goldman Sachs Group Inc., Research Division - Equity Analyst
* Michael Leuchten
UBS Investment Bank, Research Division - Co-Head of Pharmaceuticals Research of Equity Research
* Peter Verdult
Citigroup Inc, Research Division - MD
* Peter Sehested
Handelsbanken Capital Markets AB, Research Division - Research Analyst
* Richard Vosser
JP Morgan Chase & Co, Research Division - Senior Analyst
*

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot